Psilocybin
What you gain
A short, supported course with the clearest anxiety data in serious illness.
What it asks of you
Self-pay, full dosing days, and less certainty for everyday anxiety.
Comparison guide
Psilocybin or IV Ketamine for Anxiety
IV ketamine can move anxiety scores quickly. Psilocybin’s clearest anxiety studies are in people facing serious illness — not everyday worry.
Answers at a glance
Comprehensive comparison
Psilocybin
In cancer-related studies, change showed up early; key check-ins were around 5–7 weeks.12
IV Ketamine
Anxiety scores can shift within hours; pooled benefit often lasts about 1–2 weeks per dose.45
Psilocybin
Illness-related trials reported lasting benefit across follow-up windows of weeks to months.12
IV Ketamine
Without more doses, anxiety effects are often measured in days to a couple of weeks.4
Psilocybin
Nothing to taper. Integration and ongoing support are what you carry forward.
IV Ketamine
There is no standard maintenance plan for primary anxiety — benefits may fade between visits.
Psilocybin
Usually one supported dosing day plus preparation and integration.12
IV Ketamine
No validated standard anxiety course; studies used one dose or a short series.3
Psilocybin
Legal OR/CO guided courses often about $850–$4,500+ self-pay.6
IV Ketamine
About $400–$800 per clinic visit, usually out of pocket for anxiety.7
Psilocybin
Almost never for guided psilocybin.6
IV Ketamine
Almost never when used off-label for anxiety alone.
Psilocybin
Good carefully controlled studies in cancer-related anxiety; much less evidence for everyday anxiety disorders.12
IV Ketamine
Early studies only — some positive signals, not a settled first-line anxiety treatment.34
References & sources
- 1Griffiths et al. (2016). Psilocybin for cancer-related anxiety and depression. View study →
- 2Ross et al. (2016). Psilocybin for cancer-related anxiety and depression. View study →
- 3Whittaker et al. (2021). Review of ketamine studies for anxiety disorders. View study →
- 4Hartland et al. (2023). Combined review of ketamine’s short-term anxiety effects. View study →
- 5Glue et al. (2019). Ketamine for hard-to-treat generalized and social anxiety. View study →
- 6Oregon Health Authority. Accessing psilocybin services. View study →
- 7Indicative US IV ketamine cash-price ranges. View study →
Typical US ranges and outcomes; your care depends on screening and clinical need. Not medical advice.
Considerations
Every path has a trade
IV Ketamine
What you gain
Fast score changes and short clinic visits.
What it asks of you
Often short-lived benefit, no settled anxiety protocol, and rare coverage.